Johnson & Johnson Analyst EPS Estimates
Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
---|---|---|---|---|
Q1 2024 | 7 | $2.65 | $2.66 | $2.66 |
Q2 2024 | 7 | $2.71 | $2.71 | $2.71 |
Q3 2024 | 7 | $2.19 | $2.22 | $2.21 |
Q4 2024 | 10 | $1.92 | $2.30 | $2.02 |
Q1 2025 | 4 | $2.62 | $2.69 | $2.66 |
Q2 2025 | 2 | $2.69 | $2.76 | $2.72 |
Q3 2025 | 2 | $2.65 | $2.73 | $2.68 |
Q4 2025 | 2 | $2.49 | $2.56 | $2.52 |
Q1 2026 | 1 | $2.66 | $2.74 | $2.69 |
Q2 2026 | 1 | $2.79 | $2.87 | $2.82 |
Q3 2026 | 1 | $2.61 | $2.69 | $2.64 |
Q4 2026 | 1 | $2.77 | $2.85 | $2.81 |
Johnson & Johnson Earnings Date And Information
Johnson & Johnson last posted its earnings results on Tuesday, October 15th, 2024. The company reported $2.42 earnings per share for the quarter, topping analysts' consensus estimates of $2.21 by $0.21. The company had revenue of 22.47 B for the quarter and had revenue of 85.16 B for the year. Johnson & Johnson has generated $14 earnings per share over the last year ($13.72 diluted earnings per share) and currently has a price-to-earnings ratio of 25.91. Johnson & Johnson has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, January 21st, 2025 based on prior year's report dates.
Johnson & Johnson Earnings History by Quarter
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
---|---|---|---|---|---|---|
10/23/2024 | Q3 2024 | $1.11 | $22.17 B | $22.47 B | ||
07/25/2024 | Q2 2024 | $1.95 | $22.45 B | |||
05/01/2024 | Q1 2024 | $1.35 | $21.38 B | |||
02/16/2024 | Q4 2023 | $1.68 | $21.40 B | |||
10/27/2023 | Q3 2023 | $10.32 | $21.35 B | |||
07/31/2023 | Q2 2023 | $1.98 | $21.52 B | |||
04/28/2023 | Q1 2023 | -$0.03 | $20.89 B | |||
02/16/2023 | Q4 2022 | $1.35 | $23.71 B | |||
10/27/2022 | Q3 2022 | $1.70 | $20.00 B | |||
07/29/2022 | Q2 2022 | $1.83 | $24.02 B | |||
04/29/2022 | Q1 2022 | $1.96 | $23.43 B | |||
02/17/2022 | Q4 2021 | $1.80 | $24.80 B | |||
10/29/2021 | Q3 2021 | $1.39 | $23.34 B | |||
07/29/2021 | Q2 2021 | $2.38 | $23.31 B | |||
04/30/2021 | Q1 2021 | $2.35 | $22.32 B | |||
02/22/2021 | Q4 2020 | $0.66 | $22.48 B | |||
10/23/2020 | Q3 2020 | $1.35 | $21.08 B | |||
07/24/2020 | Q2 2020 | $1.38 | $17.61 B | $18.34 B | ||
04/29/2020 | Q1 2020 | $2.20 | $20.69 B | |||
02/18/2020 | Q4 2019 | $1.52 | $20.75 B |
Johnson & Johnson Earnings: Frequently Asked Questions
-
When is Johnson & Johnson's earnings date?
Johnson & Johnson has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, January 21st, 2025 based off last year's report dates.
-
Did Johnson & Johnson beat their earnings estimates last quarter?
In the previous quarter, Johnson & Johnson (:JNJ) reported $2.42 earnings per share (EPS) to beat the analysts' consensus estimate of $2.21 by $0.21.
-
How can I listen to Johnson & Johnson's earnings conference call?
The conference call for Johnson & Johnson's latest earnings report can be listened to online.
-
How can I read Johnson & Johnson's conference call transcript?
The conference call transcript for Johnson & Johnson's latest earnings report can be read online.
-
How much revenue does Johnson & Johnson generate each year?
Johnson & Johnson (:JNJ) has a recorded annual revenue of $85.16 B.
-
How much profit does Johnson & Johnson generate each year?
Johnson & Johnson (:JNJ) has a recorded net income of $85.16 B. Johnson & Johnson has generated $13.88 earnings per share over the last four quarters.
-
What is Johnson & Johnson's price-to-earnings ratio?
Johnson & Johnson (:JNJ) has a price-to-earnings ratio of 25.91 and price/earnings-to-growth ratio is -0.43.